Rancho Cordova's Cesca Therapeutics reports $27.2 million loss on impairment of assets

Cesca Therapeutics Inc., a Rancho Cordova-based cell therapy company, said it incurred $27.2 million in charges against earnings last quarter for impairment in the value of assets. The impairment charges include $12.7 million to goodwill and $14.5 million to intangible assets, Cesca (Nasdaq: KOOL) said Monday in a news release. The write-down in the value of assets led to a second-quarter loss of $27.2 million, compared to a loss of $1.15 million in the year-earlier quarter . Revenue declined 43…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news